MEDAPP S.A. ZY -10 (F:WQ1) — Market Cap & Net Worth
Market Cap & Net Worth: MEDAPP S.A. ZY -10 (WQ1)
MEDAPP S.A. ZY -10 (F:WQ1) has a market capitalization of $6.72 Million (€5.75 Million) as of May 5, 2026. Listed on the F stock exchange, this Germany-based company holds position #27769 globally and #2410 in its home market, demonstrating a 68.75% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MEDAPP S.A. ZY -10's stock price €0.04 by its total outstanding shares 250132454 (250.13 Million).
MEDAPP S.A. ZY -10 Market Cap History: 2021 to 2026
MEDAPP S.A. ZY -10's market capitalization history from 2021 to 2026. Data shows change from $57.61 Million to $11.05 Million (-28.52% CAGR).
MEDAPP S.A. ZY -10 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MEDAPP S.A. ZY -10's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of WQ1 by Market Capitalization
Companies near MEDAPP S.A. ZY -10 in the global market cap rankings as of May 5, 2026.
Key companies related to MEDAPP S.A. ZY -10 by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #934 globally with a market cap of $27.98 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #2199 globally with a market cap of $10.25 Billion USD ( AU$14.49 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2341 globally with a market cap of $9.34 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2450 globally with a market cap of $8.82 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #934 | Veeva Systems Inc Class A | NYSE:VEEV | $27.98 Billion | $170.22 |
| #2199 | Pro Medicus Ltd | AU:PME | $10.25 Billion | AU$138.67 |
| #2341 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $9.34 Billion | $55.81 |
| #2450 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $8.82 Billion | $53.54 |
MEDAPP S.A. ZY -10 Historical Marketcap From 2021 to 2026
Between 2021 and today, MEDAPP S.A. ZY -10's market cap moved from $57.61 Million to $ 11.05 Million, with a yearly change of -28.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €11.05 Million | +142.31% |
| 2025 | €4.56 Million | -45.07% |
| 2024 | €8.31 Million | -57.74% |
| 2023 | €19.65 Million | -16.00% |
| 2022 | €23.39 Million | -59.39% |
| 2021 | €57.61 Million | -- |
End of Day Market Cap According to Different Sources
On May 5th, 2026 the market cap of MEDAPP S.A. ZY -10 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.72 Million USD |
| MoneyControl | $6.72 Million USD |
| MarketWatch | $6.72 Million USD |
| marketcap.company | $6.72 Million USD |
| Reuters | $6.72 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About MEDAPP S.A. ZY -10
MedApp S.A. develops solutions to support diagnostic imaging and digital medicine in Poland, rest of the European Union, and internationally. The company offers CarnaLife System, an analytical telemedicine system that enables physician to assess and monitor the health of patients and conduct consultations, as well as enable remote measurement, such as pulse oximeter, electrocardiograph, blood pre… Read more